Norsk Titanium (NTI) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
23 Jan, 2026Executive summary
Achieved major commercial milestones, including long-term supply agreements with Airbus and Boeing, and first serial production order for the US Department of Defense; expanded recurring orders in the semiconductor industry.
Serial production parts increased from 8 to 28 year-over-year, tripling annual recurring revenue to $11 million.
Raised $46.1 million in gross proceeds, strengthening financial position and fully funding business plan through break-even, with strong investor support.
Focused on scaling production, cost efficiencies, and accelerating customer adoption to meet ambitious growth targets.
Transitioned 15 new part numbers into serial production, doubling the total to 26 by end of H1 2024.
Financial highlights
H1 2024 revenue grew to $1.3 million from $0.9 million year-over-year; serial production revenue rose to $0.9 million.
EBITDA loss was $12.1 million, similar to prior year; net loss increased to $27 million, mainly due to a $14–$20.5 million warrant-related expense.
Cash position improved from $1.2 million at start of year to $23.9 million at end of first half.
Cash burn increased to $2.3 million per month, in line with production ramp-up.
Operating expenses rose to $13.4 million, driven by higher raw material costs.
Outlook and guidance
Targeting 60 parts in serial production by year-end 2024, with $10–$12 million in full-year production revenue.
$50 million annual recurring revenue expected in Q1 2025, with 60 parts in production.
Break-even revenue projected at $70–$80 million by end of 2025; positive EBITDA and gross margin targets for 2026.
2026 guidance: 120 parts in production, $120–$160 million revenue, 30% EBITDA margin, and 50% gross margin.
Revised 2024 revenue forecast to $10–12 million (from $15 million) due to delays in contract negotiations and product development.
Latest events from Norsk Titanium
- Serial production ramped up, ARR tripled, and major aerospace contracts secured.NTI
H2 20249 Mar 2026 - Forging-equivalent titanium parts and OEM partnerships drive rapid commercial growth.NTI
Status update6 Mar 2026 - Guidance retracted and 2025 revenue fell to USD 4.1M, but long-term growth prospects remain strong.NTI
Q4 2025 TU25 Feb 2026 - Recurring revenue from aerospace and industrial parts drives strong growth and multi-year backlog.NTI
Small-Cap Growth Virtual Investor Conference 20243 Feb 2026 - 2024 revenue guidance cut to $6M, but 2025–2026 growth and funding targets remain strong.NTI
Q3 2024 TU18 Jan 2026 - Full-year sales surged 118% with 2025 targeting over 120 parts and $70–$90M ARR.NTI
Q4 2024 TU9 Jan 2026 - Q1 2025 revenue up, but delays and slowdowns heighten risk to 2025–2026 targets.NTI
Q1 2025 TU26 Nov 2025 - 54% revenue growth in H1 2025, but delayed aerospace ramp pushes breakeven to 2027; equity raise planned.NTI
H1 202523 Nov 2025 - Q3 revenue hit $0.63M, cash burn dropped, and new CEO and funding drive diversification.NTI
Q3 2025 TU13 Nov 2025